The impact of apathy on glycemic control in diabetes:
A cross-sectional study by Padala, Prasad R. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
U.S. Department of Veterans Affairs Staff 
Publications U.S. Department of Veterans Affairs 
2008 
The impact of apathy on glycemic control in diabetes: A cross-
sectional study 
Prasad R. Padala 
University of Nebraska Medical Center, ppadala@unmc.edu 
Cyrus V. Desouza 
University of Nebraska Medical Center, cdesouza@unmc.edu 
Stephanie Almeida 
University of Nebraska Medical Center 
Vijay Shivaswamy 
University of Nebraska Medical Center, vshivaswamy@unmc.edu 
Krishan Ariyarathna 
Creighton University 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/veterans 
Padala, Prasad R.; Desouza, Cyrus V.; Almeida, Stephanie; Shivaswamy, Vijay; Ariyarathna, Krishan; Rouse, 
Lance; Burke, William J.; and Petty, Frederick, "The impact of apathy on glycemic control in diabetes: A 
cross-sectional study" (2008). U.S. Department of Veterans Affairs Staff Publications. 62. 
https://digitalcommons.unl.edu/veterans/62 
This Article is brought to you for free and open access by the U.S. Department of Veterans Affairs at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in U.S. Department of Veterans 
Affairs Staff Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Prasad R. Padala, Cyrus V. Desouza, Stephanie Almeida, Vijay Shivaswamy, Krishan Ariyarathna, Lance 
Rouse, William J. Burke, and Frederick Petty 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
veterans/62 
The impact of apathy on glycemic control in diabetes:
A cross-sectional study
Prasad R. Padala a,b, Cyrus V. Desouza a,b,*, Stephanie Almeida b, Vijay Shivaswamy b,
Krishan Ariyarathna c, Lance Rouse b, William J. Burke b, Frederick Petty a,c
aVeterans Affairs Medical Center, Omaha, NE, United States
bUniversity of Nebraska Medical Center, Omaha, NE, United States
cCreighton University, Omaha, NE, United States
1. Introduction
Diabetes mellitus is a major public health problem. The
prevalence of diabetes in the general population in the USA is
estimated to be 6–7% [1]. Prevalence rates of diabetes in the
Department of Veterans Affairs (VA) health care system are
estimated to be 19–20% [2]. The prevalence of diabetes in the
VA Nebraska Western Iowa Healthcare System (NWIHCS) is
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Objective: Diabetes mellitus is a major public health problem with a prevalence of 6–7%. Self-
care behaviors play a major role in the control of diabetes. Apathy is characterized by loss of
initiative and motivation. Apathy may interfere with self-care behavior and glycemic
control. The primary objective was to determine the prevalence of apathy in patients with
diabetes. The secondary objective was to determine if there was an association between
clinically significant apathy and factors that affect glycemic control.
Research design and methods: We conducted a cross-sectional study of 100 patients with
diabetes who were assessed with the Apathy Evaluation Scale-Clinician version (AES-C), the
Hamilton Depression Scale (HAM-D), and the Self-Care Inventory (SCI). For this study we
defined clinically significant apathy as AES-C score of >30. We excluded patients with a
HAM-D score of >14 (n = 19) to avoid confounding from depression. T-tests were used to
compare clinical characteristics between subjects with and without apathy. Multiple linear
regression modeling was used to investigate the association between clinically significant
apathy and factors that affect glycemic control.
Results: Fifty (61.7% of 81) patients had clinically significant apathy. Compared to the non-
apathetic patients, those with apathy had a higher mean BMI (30.5 kg/m2 versus 34.1 kg/m2
( p = 0.03)) and were less likely to adhere to an exercise plan (p = 0.01) or insulin regimen
( p = 0.003). After adjustment for age, BMI, cholesterol, mild depression and the average Self-
Care Index score, the mean HbA1C level was 0.66% greater for apathetic compared to non-
apathetic subjects (P = 0.08).
Conclusion: Apathy is highly prevalent in patients with diabetes without depression. Apathy
may have a negative impact on self-care behaviors and diabetes control.
Published by Elsevier Ireland Ltd.
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20–22%, which is three times the prevalence of diabetes in the
general population [3].
The increasing prevalence of diabetes has led to an
epidemic of cardiovascular and other complications such as
blindness, end-stage renal disease, and lower limb amputa-
tions. Poor glycemic control contributes to the high incidence
of these complications [4]. Diabetes is the fifth leading cause of
death in the United States. Total cost of caring for diabetes
including the direct medical, and indirect expenditures in 2002
were estimated at US$ 132 billion [5]. Several trials have shown
that controlling the blood sugars, LDL cholesterol and blood
pressure of patients with diabetes reduce risk of these
complications. Yet less than 10% of patients with diabetes
have reached their goals in all three parameters [6]. There are
several factors why patients with diabetes may not achieve
the desired goals. Co-morbid mental illness has been found to
increase this risk.
The presence of mental illness complicates the course of
diabetes. Depression is known to be an independent risk factor
for diabetes and increases the risk of developing diabetes by
23% in younger adults [7,8]. According to a meta-analysis
conducted by de Groot et al. [9], there is a significant
association between depression and several diabetes compli-
cations. Factors that may be responsible for this increased risk
include obesity, smoking, unhealthy dietary habits and
inadequate utilization of preventative and primary health-
care, and nonadherence to medications [8].
There are conflicting data concerning the impact of
depression on glycemic control. Singh et al. showed in a Pima
Indian population that HbA1c was significantly higher in
depressed patients with diabetes when compared with those
without depression [10]. Severity of depressive symptomatol-
ogy has been linked to poorer adherence to dietary, and
medication regimen, higher functional impairment and
higher health care costs in patients with diabetes [11].
However in a large study of patients with diabetes, only a
weak relationship between depression and HbA1c was found
at baseline and the presence of depression did not prospec-
tively predict change in glycemic control [12].
Apathy, rather than depression, may predict adherence to
diabetic self-care and may have a closer link with glycemic
control. Apathy, a common behavioral problem in chronic
illnesses such as Parkinsonism, Multiple Sclerosis, Alzhei-
mer’s dementia, is a clinical syndrome that is distinct from
depression [13,14]. Self-criticism and negative outlook of
future are common emotions in depression, and are absent
in apathetic individuals, who show a lack of concern instead
which may have direct adverse impact on self-care of diabetes
[15,16]. Apathy is characterized by loss of initiation and
motivation, decreased social engagement, and emotional
indifference [15]. Apathy manifests as poor persistence, lack
of interest, blunted emotional response and lack of insight
[16]. It is common and occurs alone and together with
depression. Apathy has profound consequences on both
patients and caregivers [17]. Patients with apathy were 3.2
times more likely to have impaired activities of daily living in a
sample of patients with dementia [18].
The proper care of diabetes requires the patient to
exercise regularly, adhere to recommended diet and food
portions, keep food records, attend clinics regularly, check
blood sugars frequently and take medications or insulin at
correct times and dosages. The presence of apathy may keep
patients from adhering to this regimen and following the
self-care recommendations [19]. In one study self-reported
apathy was shown to be one of the reasons why patients
with diabetes did not return for a recommended eye
examination [20].
However, to our knowledge, there are no studies looking at
the prevalence of apathy in patients with diabetes. Further, no
systematic study has addressed the impact of apathy on
glycemic control and self-care behavior. Also, there are no
studies to examine the effect of apathy on diabetes indepen-
dent of depression. The primary objective of this study was to
determine the prevalence of apathy in patients with diabetes.
The secondary objective was to determine if there was an
association between clinically significant apathy and factors
that affect glycemic control.
2. Research design and methods
We conducted a cross-sectional study of 100 patients with
diabetes mellitus enrolled in the Diabetes Clinic, Primary Care
Clinic, Mental Health Clinic and the Recovery Center at the
Omaha Veterans Affairs Medical Center (OVAMC). The
institutional review board at OVAMC approved the study.
Patients were approached by the research team members and
invited to participate in the study and provided written
consent before participating in the study.
Each patient participated in a 60–75 min semi-structured
interview to complete the Apathy Evaluation Scale-Clinician
version (AES-C) [21], the Hamilton Rating Scale for Depression-
17 item version (HAM-D17) [22], and The Self-Care Inventory
(SCI) [23]. Nineteen patients scoring >14 on the HAM-D were
excluded from analysis to help avoid confounding from the
presence of clinically significant depression. Data from the
remaining 81 patients were analyzed.
Demographic and laboratory data were also collected from
the computerized patient record system (CPRS) on the same
day of the study. Data thus collected included age, Body Mass
Index (BMI), Hemoglobin A1C (HbA1C), serum lipids, and the
presence of other comorbid diseases. For this study clinically
significant apathy was defined as an AES-C score>30, which is
the typically used cut-off.
2.1. Statistical analysis
The data were entered in a database and analyzed using SAS
9.0 statistical software. Characteristics of patients with and
without clinically significant apathy, including HbA1c, BMI,
cholesterol levels, age, HAM-D scores and SCI scores, were
compared using two-sample t-test. Multiple linear regres-
sion was used to investigate the association between
clinically significant apathy and factors that affect glycemic
control, while adjusting for age, BMI, total cholesterol, mild
depression (HAM-D 7) and the average SCI score. Sub-
domains of apathy including motivation, persistence and
novelty were also analyzed similarly. Descriptive summaries
are presented as the mean  S.D. The significance level was
set at 0.05.
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2.2. Instruments
2.2.1. Apathy Evaluation Scale-Clinician version (AES-C)
[15]
AES-C has been specifically developed to assess apathy and
discriminate it from depression. This 18-item scale with scores
ranging from 18 to 72 assesses apathy in behavioral, cognitive
and emotional domains over the previous four weeks. Three
questions have negative syntax to ensure validity of
responses. A semi-structured interview is conducted to obtain
information from the patient. The AES-C has good internal
consistency (coefficient alpha = 0.86), and test–retest reliabil-
ity (r = 0.76). A score of >30 is considered clinically significant
apathy [21]. Apathy is divided into three sub-domains of
persistence, motivation and novelty since the deficits in each
of these sub-domains could differentially impact the out-
comes. The sub-domains of apathy were obtained by
combining the responses to questions in the AES-C that
targeted the specific construct. Persistence domain was
derived from responses to questions 9 ‘Seeing a job through
is important to him/her’ and 10 ‘S/he spends time doing things
that interest him/her’. Motivation domain consisted of
questions 1 ‘S/he is interested in things’, 16 ‘Getting things
done during the day is important to him/her’ and 18 ‘S/he has
motivation’. Novelty domain was derived using questions 3 ‘S/
he is interested in having new experiences’ and 4 ‘S/he is
interested in learning new things’ [21]. The cutoffs for sub-
domains were obtained using the same model used for the
AES-C score adjusted to the number of questions. A score of3
was considered as intact initiative and persistence and a score
of 5 was considered intact motivation.
2.2.2. Hamilton Rating Scale for Depression (HAM-D17) [16]
The 17-item version of the HAM-D was used for this study [22].
The HAM-D17 is widely used for rating the severity of the
symptoms depression and a score of > 14 is typically
considered as mild to moderate depression. A score of < 7 is
usually considered as being free of depression in clinical trials.
2.2.3. The Self-Care Inventory (SCI) [17]
The SCI is a measure of perceptions of adherence to diabetes
self-care recommendations. 14 items targeting adherence to
various diabetes self-care recommendations over the previous
month are scored on a Likert scale ranging from 1 ‘‘never do it’’
to 5 ‘‘always do this as recommended without fail’’. Five items
target insulin and food regulation, four items concern blood
glucose regulation, two items target exercise, two target
emergency precautions and one item targets attendance to
appointments. The SCI has a good internal consistency
(coefficient alpha > 0.80), and test–retest reliability (r > 0.77)
[23]. The authors have previously identified 7 of the 14 items to
be linked with better diabetes management and control [23].
These items include #1, 2, 5, 6, 7, 8 and 13; aggregates of these
items have been used in our analysis.
3. Results
Hundred consecutive patients were enrolled and interviewed,
19 of whom had scores greater than 14 on the HAM-D and were
thus excluded from analysis to avoid confounding. Data from
the remaining 81 patients was analyzed.
The mean age of the 81 patients was 58.60  11.99 years, 76
(94%) patients were male, 71 (88%) were Caucasian, 9 (11%)
were African American and 1 patient was Hispanic American.
The mean apathy score was 36.17  11.19, indicating clinically
significant apathy in this population. The mean HAM-D score
was 6.52  3.72 indicating a lack of clinically significant
depression in this population. Thus, the 81 patients included
in the analysis had an apathy syndrome without depression.
Other demographic data and baseline values are presented in
Table 1.
Fifty of the 81 patients (61.7%) had clinically significant
apathy (AES-C > 30). After adjustment for age, BMI, choles-
terol, mild depression, and the 7-item diabetes SCI average
score, the mean HbA1C levels was 0.66% higher (absolute
difference) for subjects with apathy compared to subjects
without apathy, which was not statistically significant
(p = 0.08), but had a definite trend to being higher.
Patients with apathy had a higher mean BMI (34.07 versus
30.46, p = 0.03). Patients with apathy were less likely to adhere
Table 1 – Demographics: mean (N = 81)
Age (years) 58.6 (11.9)
Male 94%
Caucasian 88%
African American 11%
Hispanic 1%
Apathy score 36.17 (11.19)
HbA1C (%) 8.1 (1.7)
HAM-D 6.5 (3.7)
BMI 32.7 (7.3)
Total cholesterol (mg/dL) 179.9 (49.4)
Table 2 – Impact of apathy on self-care of diabetes, BMI and the glycemic control
Variable No Apathy (AES  30) Apathy (AES > 30) p-value
HbA1C (%) (multivariate analysis) 7.64 (1.49) 8.3 (1.55) 0.08
BMI 30.5 (7.14) 34.1 (7.09) 0.03*
Adherence to a meal plana 3.32 (1.14) 3.02 (1.11) 0.243
Adherence to an exercise plana 3.45 (1.48) 2.64 (1.41) 0.019*
Administering correct dose of insulina 4.88 (0.34) 4.44 (0.61) 0.003*
Measuring glucose regularlya 4.23 (1.05) 3.83 (1.18) 0.132
a From the Self-Care Inventory: 1 = never do it, 3 = follow recommendations about 50% of the time, 5 = always do this as recommended without
fail  is S.D.
* p < 0.05 vs. no apathy.
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to an exercise plan (p = 0.01) or to administer the correct doses
of insulin (p = 0.003) when compared to those without apathy
(Table 2). There were no significant differences in patients
with and without apathy in terms of adherence to meal plans
or measuring subcutaneous glucose regularly.
We further tested the impact of the sub-domains of apathy
on glycemic control. The lack of persistence was significantly
associated with poor glycemic control (7.83 versus 8.53,
p = 0.04), whereas the lack of motivation showed a trend
towards association with poor glycemic control (7.74 versus
8.37, p = 0.08) (Table 3). The lack of novelty had no association
with poor glycemic control (8.0 versus 8.15, p = 0.84).
4. Discussion
The primary finding in this study is a high prevalence of
apathy (62% clinically significant apathy) in this cohort of
predominantly white, male veteran population with diabetes.
This is the first study to the best of our knowledge that
assesses the prevalence of apathy in such a population.
Generalizability of this data may be limited due to the gender
bias; nevertheless the high prevalence of apathy in patients
with diabetes is alarming. The mean apathy score was 36.17
despite the mean scores on the HAM-D being 6.52. This
indicates that clinically significant apathy can exist in the
absence of depression. Similar discordance between apathy
and depression has been reported in other chronic illnesses
such as dementia [9]. Even more alarming is the fact that
apathy was not diagnosed in any of these patients on a clinical
basis prior to our study.
The secondary finding of the study shows that factors that
are important in glycemic control were significantly affected
by apathy. Patients with apathy had significantly higher BMI
when compared to those without apathy. Patients with apathy
were also less likely to follow an exercise plan or to take their
insulin as instructed. Diabetes control itself as measured by
HbA1c trended higher (0.66%) in patients with apathy but
failed to reach statistical significance. Together these suggest
that patients with apathy are likely to exhibit behaviors that
worsen diabetes control and thus its complications. The fact
that these associations may exist in a population devoid of
clinically significant depression, suggests that apathy may
have a significant role in factors that affect glycemic control.
This strengthens our hypothesis that the presence of apathy
impairs self-care, thus the treatment of apathy opens another
avenue to impact the control of diabetes.
We further tested if the subdomains of apathy, lack of
persistence, motivation and initiative were linked to poor
glycemic control. Diabetes patients with a lack of persistence
and motivation had a higher HbA1c. This further suggests that
a lack of persistence and motivation may be major con-
tributors to the inability of some diabetes patients to adhere to
self-care behaviors.
The clinical implications of these findings could be
substantial. Apathy may be highly prevalent in patients with
diabetes. Apathy may be associated with poor control of
factors that affect diabetes, weight gain and may often go un-
diagnosed. Clinicians and educators may want to screen for
apathy routinely in clinical care of patients with diabetes,
especially in patients with poor control. Although the AES-C is
an excellent rating scale for apathy, the time needed to
complete this scale may hinder practical use of this rating
scale in routine clinical practice. The patient/caregiver rated
versions of AES may help detect apathy reliably without added
burden on the physician. Another useful screen in busy
clinical practice are the four screening questions from the
apathy domain of the Neuropsychiatric Inventory (NPI). ‘Has
the patient lost interest in the world around him/her?’, ‘Has
he/she lost interest in doing things or lacks motivation for
starting new activities?’, ‘Is he/she more difficult to engage in
conversation or in doing chores?’, and ‘Is the patient apathetic
or indifferent?’ [24]. More detailed testing will be needed if the
patient endorses any of the screening questions.
Several agents have been used for the treatment of apathy,
including methylphenidate, cholinesterase inhibitors, bupro-
pion, bromocriptine, and modafinil [25–29]. Large randomized
trials testing these agents are however lacking. Although it is
plausible that self-care behaviors and factors that are important
for diabetes control, could improve with successful treatment of
apathy, it needs to be tested in systematic studies.
Limitations of this study include but are not limited to its
cross-sectional design. Prospective studies, including the
assessment of apathy at the time of the initial diagnosis of
diabetes, and periodic re-assessments of apathy over a period
of a few years is necessary to establish any causal relation.
Comorbid conditions were not accounted for systematically,
use of a risk adjustment measure such as the Charlson Index
could improve the methodology of future studies. 94% of the
patients in this study were male as it was conducted in the VA,
it will be interesting to investigate gender differences in future
studies.
In conclusion, our study in the predominantly male veteran
population, found a high prevalence of apathy in patients with
diabetes. Patients with apathy were less likely to adhere to
self-care behaviors that influence diabetes control and had a
higher BMI. Diabetes control itself as measured by HbA1c
trended higher in patients with apathy but failed to reach
statistical significance.
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